Neurosonographic Findings in Pregnant Women With Vitamin D Deficiency

Evaluation of Neurosonographic Findings in Pregnant Women With Vitamin D Deficiency

Status

Enrolling by invitation

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06903247

Enrollment

100

Registered

2025-03-30

Start date

2025-03-15

Completion date

2025-11-30

Last updated

2025-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurosonographic Findings of Vitamin D Deficiency

Keywords

Neurosonography Vitamin D Deficiency Pregnancy

Brief summary

In the study, the potential effects of vitamin D deficiency on fetal neurodevelopmental parameters will be examined. In this context, fetal brain development will be compared between pregnant women with and without vitamin D deficiency, revealing the possible neurodevelopmental outcomes of vitamin D deficiency during the prenatal period.

Detailed description

Vitamin D is a vitamin that regulates calcium and phosphorus balance in the body and plays a crucial role in bone health. Additionally, it is known to have effects on immune system functions and neurological health. Pregnancy is a period in which vitamin D requirements increase, and vitamin D deficiency can lead to various health problems. It is believed that vitamin D deficiency may have adverse effects on fetal neurological development and may be associated with certain pathological conditions during pregnancy. Neurosonography is a critical tool for assessing the effects of prematurity, vitamin D deficiency, and other pregnancy complications on the fetus. This article will focus on the evaluation of neurosonographic findings in pregnant women with vitamin D deficiency.

Interventions

OTHERNeurosonographic Findings of Vitamin D Deficiency in Single Healthy Pregnancies Presenting for Routine Antenatal Care Between 20-30 Weeks of Gestation.

Comparison of Neurosonographic Findings in Patients with and without Vitamin D Deficiency.

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 50 Years

Healthy volunteers

Yes

Inclusion criteria

Patients presenting for routine antenatal care between 20-30 weeks of gestation will be included.

Exclusion criteria

Multiple pregnancy, preterm rupture of membranes, chorioamnionitis, placental abruption, severe fetal growth restriction, congenital fetal anomalies, preeclampsia, oligohydramnios and maternal diabetes.

Design outcomes

Primary

Measure	Time frame
Pregnant women with vitamin D deficiency who present for routine antenatal care between 20-30 weeks of gestation.	Neurosonogram Results Performed Between 20-30 Weeks of Gestation.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026